Anteris Technologies Global Corp.

Link: https://www.medtechanalysis.com/companies/anteris-technologies-ltd

Short Description: The company’s core product, the DurAVR Transcatheter Heart Valve, is made from bovine (cow) pericardium tissue (By-product). Furthermore, their developmental process has included pre-clinical “animal study/studies” for safety and performance testing of their valves and delivery systems, a practice common in medical device development. Exact Quote from Link: “The material from which the DurAVR leaflet is made is bovine pericardium tissue that has been treated with the company’s patented anti-calcification process, called Adapt.” (Proof of animal by-product) “TAVR animal study: the company commenced implanting the DurAVR™ valve into nine animals to inform development of proprietary catheter for use in human trials in CY2021.” (Proof of animal testing, from snippet 3.2, which is linked to an analysis document)